$1.47
0.021.38%
Last update: Oct 27, 9:29 AM
Lipocine Inc (LPCN) Stock Price, Quote, News & History
LPCNNASDAQ
Canada approves Lipocine’s TLANDO for adult males with testosterone deficiency. Partner Verity Pharma plans a launch by the end of 2026.
You can purchase shares of Lipocine (NASDAQ:LPCN) through any online brokerage.
Other companies in Lipocine’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Lipocine has a consensus price target of $7.00.
The stock price for Lipocine (NASDAQ: LPCN) is $1.47 last updated October 27, 2026 at 9:29 AM EDT.
There are no upcoming dividends for Lipocine.
Lipocine does not have any upcoming earnings scheduled.
There is no upcoming split for Lipocine.
Lipocine is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Lipocine Inc is a clinical-stage biopharmaceutical company that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing...
